FDA Approved: RISEDRONATE SODIUM — Original Application (Aurobindo Pharma Limited)

View source ↗

Summary

The FDA approved Aurobindo Pharma Limited's original ANDA for risedronate sodium, a generic osteoporosis treatment, enabling market entry.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glucocorticoid-induced Osteoporosis
• Osteoporosis
• Paget Disease of Bone

Drugs mentioned

• RISEDRONATE SODIUM (RISEDRONATE SODIUM)

Snippet

ORIG AP for RISEDRONATE SODIUM (RISEDRONATE SODIUM)